nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Neuropathy peripheral—Capecitabine—colon cancer	0.00146	0.00146	CcSEcCtD
Temozolomide—Oedema—Vincristine—colon cancer	0.00146	0.00146	CcSEcCtD
Temozolomide—Anaphylactic shock—Vincristine—colon cancer	0.00146	0.00146	CcSEcCtD
Temozolomide—Stomatitis—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Temozolomide—Infection—Vincristine—colon cancer	0.00145	0.00145	CcSEcCtD
Temozolomide—Urinary tract infection—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Temozolomide—Convulsion—Fluorouracil—colon cancer	0.00144	0.00144	CcSEcCtD
Temozolomide—Confusional state—Irinotecan—colon cancer	0.00143	0.00143	CcSEcCtD
Temozolomide—Nervous system disorder—Vincristine—colon cancer	0.00143	0.00143	CcSEcCtD
Temozolomide—Thrombocytopenia—Vincristine—colon cancer	0.00143	0.00143	CcSEcCtD
Temozolomide—Oedema—Irinotecan—colon cancer	0.00142	0.00142	CcSEcCtD
Temozolomide—Anaphylactic shock—Irinotecan—colon cancer	0.00142	0.00142	CcSEcCtD
Temozolomide—Myalgia—Fluorouracil—colon cancer	0.00142	0.00142	CcSEcCtD
Temozolomide—Infection—Irinotecan—colon cancer	0.00141	0.00141	CcSEcCtD
Temozolomide—Hyperhidrosis—Vincristine—colon cancer	0.00141	0.00141	CcSEcCtD
Temozolomide—Hepatobiliary disease—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Temozolomide—Discomfort—Fluorouracil—colon cancer	0.0014	0.0014	CcSEcCtD
Temozolomide—Nervous system disorder—Irinotecan—colon cancer	0.00139	0.00139	CcSEcCtD
Temozolomide—Thrombocytopenia—Irinotecan—colon cancer	0.00139	0.00139	CcSEcCtD
Temozolomide—Anorexia—Vincristine—colon cancer	0.00139	0.00139	CcSEcCtD
Temozolomide—Hyperhidrosis—Irinotecan—colon cancer	0.00137	0.00137	CcSEcCtD
Temozolomide—Confusional state—Fluorouracil—colon cancer	0.00137	0.00137	CcSEcCtD
Temozolomide—Mood swings—Methotrexate—colon cancer	0.00136	0.00136	CcSEcCtD
Temozolomide—Anaphylactic shock—Fluorouracil—colon cancer	0.00136	0.00136	CcSEcCtD
Temozolomide—Oedema—Fluorouracil—colon cancer	0.00136	0.00136	CcSEcCtD
Temozolomide—Anorexia—Irinotecan—colon cancer	0.00135	0.00135	CcSEcCtD
Temozolomide—Ataxia—Methotrexate—colon cancer	0.00135	0.00135	CcSEcCtD
Temozolomide—Infection—Fluorouracil—colon cancer	0.00135	0.00135	CcSEcCtD
Temozolomide—Haemoglobin—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Temozolomide—Hepatitis—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Temozolomide—Haemorrhage—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Temozolomide—Nervous system disorder—Fluorouracil—colon cancer	0.00133	0.00133	CcSEcCtD
Temozolomide—Thrombocytopenia—Fluorouracil—colon cancer	0.00133	0.00133	CcSEcCtD
Temozolomide—Hypoaesthesia—Capecitabine—colon cancer	0.00133	0.00133	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Vincristine—colon cancer	0.00133	0.00133	CcSEcCtD
Temozolomide—Pharyngitis—Capecitabine—colon cancer	0.00133	0.00133	CcSEcCtD
Temozolomide—Urinary tract disorder—Capecitabine—colon cancer	0.00132	0.00132	CcSEcCtD
Temozolomide—Insomnia—Vincristine—colon cancer	0.00132	0.00132	CcSEcCtD
Temozolomide—Oedema peripheral—Capecitabine—colon cancer	0.00132	0.00132	CcSEcCtD
Temozolomide—Connective tissue disorder—Capecitabine—colon cancer	0.00131	0.00131	CcSEcCtD
Temozolomide—Urethral disorder—Capecitabine—colon cancer	0.00131	0.00131	CcSEcCtD
Temozolomide—Paraesthesia—Vincristine—colon cancer	0.00131	0.00131	CcSEcCtD
Temozolomide—Breast disorder—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Temozolomide—Anorexia—Fluorouracil—colon cancer	0.0013	0.0013	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Temozolomide—Visual impairment—Capecitabine—colon cancer	0.00129	0.00129	CcSEcCtD
Temozolomide—Insomnia—Irinotecan—colon cancer	0.00128	0.00128	CcSEcCtD
Temozolomide—Paraesthesia—Irinotecan—colon cancer	0.00128	0.00128	CcSEcCtD
Temozolomide—Decreased appetite—Vincristine—colon cancer	0.00127	0.00127	CcSEcCtD
Temozolomide—Dyspnoea—Irinotecan—colon cancer	0.00127	0.00127	CcSEcCtD
Temozolomide—Erythema multiforme—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Temozolomide—Somnolence—Irinotecan—colon cancer	0.00126	0.00126	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Vincristine—colon cancer	0.00126	0.00126	CcSEcCtD
Temozolomide—Fatigue—Vincristine—colon cancer	0.00126	0.00126	CcSEcCtD
Temozolomide—Eye disorder—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Temozolomide—Dyspepsia—Irinotecan—colon cancer	0.00125	0.00125	CcSEcCtD
Temozolomide—Tinnitus—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Temozolomide—Pain—Vincristine—colon cancer	0.00125	0.00125	CcSEcCtD
Temozolomide—Constipation—Vincristine—colon cancer	0.00125	0.00125	CcSEcCtD
Temozolomide—Cardiac disorder—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Temozolomide—Flushing—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00124	0.00124	CcSEcCtD
Temozolomide—Decreased appetite—Irinotecan—colon cancer	0.00123	0.00123	CcSEcCtD
Temozolomide—Insomnia—Fluorouracil—colon cancer	0.00123	0.00123	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Irinotecan—colon cancer	0.00123	0.00123	CcSEcCtD
Temozolomide—Fatigue—Irinotecan—colon cancer	0.00122	0.00122	CcSEcCtD
Temozolomide—Paraesthesia—Fluorouracil—colon cancer	0.00122	0.00122	CcSEcCtD
Temozolomide—Constipation—Irinotecan—colon cancer	0.00121	0.00121	CcSEcCtD
Temozolomide—Pain—Irinotecan—colon cancer	0.00121	0.00121	CcSEcCtD
Temozolomide—Angiopathy—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Temozolomide—Dyspnoea—Fluorouracil—colon cancer	0.00121	0.00121	CcSEcCtD
Temozolomide—Somnolence—Fluorouracil—colon cancer	0.00121	0.00121	CcSEcCtD
Temozolomide—Immune system disorder—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Temozolomide—Mediastinal disorder—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Temozolomide—Chills—Capecitabine—colon cancer	0.0012	0.0012	CcSEcCtD
Temozolomide—Dyspepsia—Fluorouracil—colon cancer	0.0012	0.0012	CcSEcCtD
Temozolomide—Gastrointestinal pain—Vincristine—colon cancer	0.00119	0.00119	CcSEcCtD
Temozolomide—Decreased appetite—Fluorouracil—colon cancer	0.00118	0.00118	CcSEcCtD
Temozolomide—Alopecia—Capecitabine—colon cancer	0.00118	0.00118	CcSEcCtD
Temozolomide—Pancytopenia—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00117	0.00117	CcSEcCtD
Temozolomide—Mental disorder—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Temozolomide—Feeling abnormal—Irinotecan—colon cancer	0.00117	0.00117	CcSEcCtD
Temozolomide—Malnutrition—Capecitabine—colon cancer	0.00116	0.00116	CcSEcCtD
Temozolomide—Erythema—Capecitabine—colon cancer	0.00116	0.00116	CcSEcCtD
Temozolomide—Dysuria—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Temozolomide—Neutropenia—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Temozolomide—Pain—Fluorouracil—colon cancer	0.00116	0.00116	CcSEcCtD
Temozolomide—Gastrointestinal pain—Irinotecan—colon cancer	0.00116	0.00116	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Temozolomide—Body temperature increased—Vincristine—colon cancer	0.00115	0.00115	CcSEcCtD
Temozolomide—Abdominal pain—Vincristine—colon cancer	0.00115	0.00115	CcSEcCtD
Temozolomide—Erectile dysfunction—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Temozolomide—Dysgeusia—Capecitabine—colon cancer	0.00114	0.00114	CcSEcCtD
Temozolomide—Photosensitivity reaction—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Temozolomide—Back pain—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Temozolomide—Abdominal pain—Irinotecan—colon cancer	0.00112	0.00112	CcSEcCtD
Temozolomide—Body temperature increased—Irinotecan—colon cancer	0.00112	0.00112	CcSEcCtD
Temozolomide—Feeling abnormal—Fluorouracil—colon cancer	0.00112	0.00112	CcSEcCtD
Temozolomide—Pneumonia—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Temozolomide—Infestation NOS—Methotrexate—colon cancer	0.00111	0.00111	CcSEcCtD
Temozolomide—Infestation—Methotrexate—colon cancer	0.00111	0.00111	CcSEcCtD
Temozolomide—Depression—Methotrexate—colon cancer	0.00111	0.00111	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Temozolomide—Vision blurred—Capecitabine—colon cancer	0.0011	0.0011	CcSEcCtD
Temozolomide—Tremor—Capecitabine—colon cancer	0.00109	0.00109	CcSEcCtD
Temozolomide—Stomatitis—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Temozolomide—Ill-defined disorder—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Temozolomide—Urticaria—Fluorouracil—colon cancer	0.00108	0.00108	CcSEcCtD
Temozolomide—Anaemia—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Temozolomide—Body temperature increased—Fluorouracil—colon cancer	0.00108	0.00108	CcSEcCtD
Temozolomide—Hypersensitivity—Vincristine—colon cancer	0.00107	0.00107	CcSEcCtD
Temozolomide—Malaise—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Temozolomide—Hepatobiliary disease—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Temozolomide—Vertigo—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Temozolomide—Hypersensitivity—Irinotecan—colon cancer	0.00105	0.00105	CcSEcCtD
Temozolomide—Asthenia—Vincristine—colon cancer	0.00105	0.00105	CcSEcCtD
Temozolomide—Leukopenia—Capecitabine—colon cancer	0.00104	0.00104	CcSEcCtD
Temozolomide—Palpitations—Capecitabine—colon cancer	0.00103	0.00103	CcSEcCtD
Temozolomide—Asthenia—Irinotecan—colon cancer	0.00102	0.00102	CcSEcCtD
Temozolomide—Cough—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Temozolomide—Hypertension—Capecitabine—colon cancer	0.00101	0.00101	CcSEcCtD
Temozolomide—Hypersensitivity—Fluorouracil—colon cancer	0.001	0.001	CcSEcCtD
Temozolomide—Haemoglobin—Methotrexate—colon cancer	0.001	0.001	CcSEcCtD
Temozolomide—Diarrhoea—Vincristine—colon cancer	0.000998	0.000998	CcSEcCtD
Temozolomide—Haemorrhage—Methotrexate—colon cancer	0.000996	0.000996	CcSEcCtD
Temozolomide—Hepatitis—Methotrexate—colon cancer	0.000996	0.000996	CcSEcCtD
Temozolomide—Arthralgia—Capecitabine—colon cancer	0.000991	0.000991	CcSEcCtD
Temozolomide—Myalgia—Capecitabine—colon cancer	0.000991	0.000991	CcSEcCtD
Temozolomide—Pharyngitis—Methotrexate—colon cancer	0.000988	0.000988	CcSEcCtD
Temozolomide—Anxiety—Capecitabine—colon cancer	0.000988	0.000988	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000985	0.000985	CcSEcCtD
Temozolomide—Urinary tract disorder—Methotrexate—colon cancer	0.000984	0.000984	CcSEcCtD
Temozolomide—Discomfort—Capecitabine—colon cancer	0.00098	0.00098	CcSEcCtD
Temozolomide—Urethral disorder—Methotrexate—colon cancer	0.000976	0.000976	CcSEcCtD
Temozolomide—Diarrhoea—Irinotecan—colon cancer	0.000972	0.000972	CcSEcCtD
Temozolomide—Dry mouth—Capecitabine—colon cancer	0.00097	0.00097	CcSEcCtD
Temozolomide—Dizziness—Vincristine—colon cancer	0.000964	0.000964	CcSEcCtD
Temozolomide—Pruritus—Fluorouracil—colon cancer	0.000962	0.000962	CcSEcCtD
Temozolomide—Visual impairment—Methotrexate—colon cancer	0.00096	0.00096	CcSEcCtD
Temozolomide—Confusional state—Capecitabine—colon cancer	0.000958	0.000958	CcSEcCtD
Temozolomide—Oedema—Capecitabine—colon cancer	0.00095	0.00095	CcSEcCtD
Temozolomide—Infection—Capecitabine—colon cancer	0.000944	0.000944	CcSEcCtD
Temozolomide—Erythema multiforme—Methotrexate—colon cancer	0.000942	0.000942	CcSEcCtD
Temozolomide—Dizziness—Irinotecan—colon cancer	0.000939	0.000939	CcSEcCtD
Temozolomide—Nervous system disorder—Capecitabine—colon cancer	0.000932	0.000932	CcSEcCtD
Temozolomide—Eye disorder—Methotrexate—colon cancer	0.000931	0.000931	CcSEcCtD
Temozolomide—Diarrhoea—Fluorouracil—colon cancer	0.000931	0.000931	CcSEcCtD
Temozolomide—Thrombocytopenia—Capecitabine—colon cancer	0.000931	0.000931	CcSEcCtD
Temozolomide—Tinnitus—Methotrexate—colon cancer	0.000929	0.000929	CcSEcCtD
Temozolomide—Vomiting—Vincristine—colon cancer	0.000927	0.000927	CcSEcCtD
Temozolomide—Cardiac disorder—Methotrexate—colon cancer	0.000924	0.000924	CcSEcCtD
Temozolomide—Skin disorder—Capecitabine—colon cancer	0.000923	0.000923	CcSEcCtD
Temozolomide—Rash—Vincristine—colon cancer	0.000919	0.000919	CcSEcCtD
Temozolomide—Hyperhidrosis—Capecitabine—colon cancer	0.000919	0.000919	CcSEcCtD
Temozolomide—Dermatitis—Vincristine—colon cancer	0.000919	0.000919	CcSEcCtD
Temozolomide—Headache—Vincristine—colon cancer	0.000914	0.000914	CcSEcCtD
Temozolomide—Anorexia—Capecitabine—colon cancer	0.000906	0.000906	CcSEcCtD
Temozolomide—Angiopathy—Methotrexate—colon cancer	0.000904	0.000904	CcSEcCtD
Temozolomide—Vomiting—Irinotecan—colon cancer	0.000903	0.000903	CcSEcCtD
Temozolomide—Immune system disorder—Methotrexate—colon cancer	0.0009	0.0009	CcSEcCtD
Temozolomide—Dizziness—Fluorouracil—colon cancer	0.000899	0.000899	CcSEcCtD
Temozolomide—Mediastinal disorder—Methotrexate—colon cancer	0.000898	0.000898	CcSEcCtD
Temozolomide—Rash—Irinotecan—colon cancer	0.000895	0.000895	CcSEcCtD
Temozolomide—Dermatitis—Irinotecan—colon cancer	0.000895	0.000895	CcSEcCtD
Temozolomide—Chills—Methotrexate—colon cancer	0.000894	0.000894	CcSEcCtD
Temozolomide—Headache—Irinotecan—colon cancer	0.00089	0.00089	CcSEcCtD
Temozolomide—Alopecia—Methotrexate—colon cancer	0.00088	0.00088	CcSEcCtD
Temozolomide—Mental disorder—Methotrexate—colon cancer	0.000873	0.000873	CcSEcCtD
Temozolomide—Malnutrition—Methotrexate—colon cancer	0.000867	0.000867	CcSEcCtD
Temozolomide—Erythema—Methotrexate—colon cancer	0.000867	0.000867	CcSEcCtD
Temozolomide—Nausea—Vincristine—colon cancer	0.000866	0.000866	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000866	0.000866	CcSEcCtD
Temozolomide—Vomiting—Fluorouracil—colon cancer	0.000865	0.000865	CcSEcCtD
Temozolomide—Insomnia—Capecitabine—colon cancer	0.00086	0.00086	CcSEcCtD
Temozolomide—Rash—Fluorouracil—colon cancer	0.000858	0.000858	CcSEcCtD
Temozolomide—Dermatitis—Fluorouracil—colon cancer	0.000857	0.000857	CcSEcCtD
Temozolomide—Paraesthesia—Capecitabine—colon cancer	0.000853	0.000853	CcSEcCtD
Temozolomide—Headache—Fluorouracil—colon cancer	0.000852	0.000852	CcSEcCtD
Temozolomide—Dysgeusia—Methotrexate—colon cancer	0.000849	0.000849	CcSEcCtD
Temozolomide—Dyspnoea—Capecitabine—colon cancer	0.000847	0.000847	CcSEcCtD
Temozolomide—Nausea—Irinotecan—colon cancer	0.000844	0.000844	CcSEcCtD
Temozolomide—Back pain—Methotrexate—colon cancer	0.000839	0.000839	CcSEcCtD
Temozolomide—Dyspepsia—Capecitabine—colon cancer	0.000837	0.000837	CcSEcCtD
Temozolomide—Decreased appetite—Capecitabine—colon cancer	0.000826	0.000826	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000821	0.000821	CcSEcCtD
Temozolomide—Fatigue—Capecitabine—colon cancer	0.000819	0.000819	CcSEcCtD
Temozolomide—Vision blurred—Methotrexate—colon cancer	0.000817	0.000817	CcSEcCtD
Temozolomide—Pain—Capecitabine—colon cancer	0.000813	0.000813	CcSEcCtD
Temozolomide—Constipation—Capecitabine—colon cancer	0.000813	0.000813	CcSEcCtD
Temozolomide—Nausea—Fluorouracil—colon cancer	0.000808	0.000808	CcSEcCtD
Temozolomide—Ill-defined disorder—Methotrexate—colon cancer	0.000804	0.000804	CcSEcCtD
Temozolomide—Anaemia—Methotrexate—colon cancer	0.000801	0.000801	CcSEcCtD
Temozolomide—Feeling abnormal—Capecitabine—colon cancer	0.000783	0.000783	CcSEcCtD
Temozolomide—Malaise—Methotrexate—colon cancer	0.000782	0.000782	CcSEcCtD
Temozolomide—Vertigo—Methotrexate—colon cancer	0.000779	0.000779	CcSEcCtD
Temozolomide—Gastrointestinal pain—Capecitabine—colon cancer	0.000777	0.000777	CcSEcCtD
Temozolomide—Leukopenia—Methotrexate—colon cancer	0.000776	0.000776	CcSEcCtD
Temozolomide—Cough—Methotrexate—colon cancer	0.000757	0.000757	CcSEcCtD
Temozolomide—Urticaria—Capecitabine—colon cancer	0.000755	0.000755	CcSEcCtD
Temozolomide—Abdominal pain—Capecitabine—colon cancer	0.000751	0.000751	CcSEcCtD
Temozolomide—Body temperature increased—Capecitabine—colon cancer	0.000751	0.000751	CcSEcCtD
Temozolomide—Convulsion—Methotrexate—colon cancer	0.000751	0.000751	CcSEcCtD
Temozolomide—Arthralgia—Methotrexate—colon cancer	0.000738	0.000738	CcSEcCtD
Temozolomide—Myalgia—Methotrexate—colon cancer	0.000738	0.000738	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000733	0.000733	CcSEcCtD
Temozolomide—Discomfort—Methotrexate—colon cancer	0.000729	0.000729	CcSEcCtD
Temozolomide—Confusional state—Methotrexate—colon cancer	0.000713	0.000713	CcSEcCtD
Temozolomide—Anaphylactic shock—Methotrexate—colon cancer	0.000708	0.000708	CcSEcCtD
Temozolomide—Infection—Methotrexate—colon cancer	0.000703	0.000703	CcSEcCtD
Temozolomide—Hypersensitivity—Capecitabine—colon cancer	0.0007	0.0007	CcSEcCtD
Temozolomide—Nervous system disorder—Methotrexate—colon cancer	0.000694	0.000694	CcSEcCtD
Temozolomide—Thrombocytopenia—Methotrexate—colon cancer	0.000693	0.000693	CcSEcCtD
Temozolomide—Skin disorder—Methotrexate—colon cancer	0.000687	0.000687	CcSEcCtD
Temozolomide—Hyperhidrosis—Methotrexate—colon cancer	0.000684	0.000684	CcSEcCtD
Temozolomide—Asthenia—Capecitabine—colon cancer	0.000682	0.000682	CcSEcCtD
Temozolomide—Anorexia—Methotrexate—colon cancer	0.000674	0.000674	CcSEcCtD
Temozolomide—Pruritus—Capecitabine—colon cancer	0.000672	0.000672	CcSEcCtD
Temozolomide—Diarrhoea—Capecitabine—colon cancer	0.00065	0.00065	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000645	0.000645	CcSEcCtD
Temozolomide—Insomnia—Methotrexate—colon cancer	0.00064	0.00064	CcSEcCtD
Temozolomide—Paraesthesia—Methotrexate—colon cancer	0.000635	0.000635	CcSEcCtD
Temozolomide—Dyspnoea—Methotrexate—colon cancer	0.000631	0.000631	CcSEcCtD
Temozolomide—Somnolence—Methotrexate—colon cancer	0.000629	0.000629	CcSEcCtD
Temozolomide—Dizziness—Capecitabine—colon cancer	0.000629	0.000629	CcSEcCtD
Temozolomide—Dyspepsia—Methotrexate—colon cancer	0.000623	0.000623	CcSEcCtD
Temozolomide—Decreased appetite—Methotrexate—colon cancer	0.000615	0.000615	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000611	0.000611	CcSEcCtD
Temozolomide—Fatigue—Methotrexate—colon cancer	0.00061	0.00061	CcSEcCtD
Temozolomide—Pain—Methotrexate—colon cancer	0.000605	0.000605	CcSEcCtD
Temozolomide—Vomiting—Capecitabine—colon cancer	0.000604	0.000604	CcSEcCtD
Temozolomide—Rash—Capecitabine—colon cancer	0.000599	0.000599	CcSEcCtD
Temozolomide—Dermatitis—Capecitabine—colon cancer	0.000599	0.000599	CcSEcCtD
Temozolomide—Headache—Capecitabine—colon cancer	0.000595	0.000595	CcSEcCtD
Temozolomide—Feeling abnormal—Methotrexate—colon cancer	0.000583	0.000583	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methotrexate—colon cancer	0.000579	0.000579	CcSEcCtD
Temozolomide—Nausea—Capecitabine—colon cancer	0.000565	0.000565	CcSEcCtD
Temozolomide—Urticaria—Methotrexate—colon cancer	0.000562	0.000562	CcSEcCtD
Temozolomide—Abdominal pain—Methotrexate—colon cancer	0.000559	0.000559	CcSEcCtD
Temozolomide—Body temperature increased—Methotrexate—colon cancer	0.000559	0.000559	CcSEcCtD
Temozolomide—Hypersensitivity—Methotrexate—colon cancer	0.000521	0.000521	CcSEcCtD
Temozolomide—Asthenia—Methotrexate—colon cancer	0.000508	0.000508	CcSEcCtD
Temozolomide—Pruritus—Methotrexate—colon cancer	0.000501	0.000501	CcSEcCtD
Temozolomide—Diarrhoea—Methotrexate—colon cancer	0.000484	0.000484	CcSEcCtD
Temozolomide—Dizziness—Methotrexate—colon cancer	0.000468	0.000468	CcSEcCtD
Temozolomide—Vomiting—Methotrexate—colon cancer	0.00045	0.00045	CcSEcCtD
Temozolomide—Rash—Methotrexate—colon cancer	0.000446	0.000446	CcSEcCtD
Temozolomide—Dermatitis—Methotrexate—colon cancer	0.000446	0.000446	CcSEcCtD
Temozolomide—Headache—Methotrexate—colon cancer	0.000443	0.000443	CcSEcCtD
Temozolomide—Nausea—Methotrexate—colon cancer	0.00042	0.00042	CcSEcCtD
